These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11157381

  • 21. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RA.
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [Abstract] [Full Text] [Related]

  • 22. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [Abstract] [Full Text] [Related]

  • 23. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP, Federspiel C, Helderman H, Fogo AB.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [Abstract] [Full Text] [Related]

  • 24. CD45RO and CD45RA positive cell populations in idiopathic membranous and IgA glomerulopathy.
    Lee AH, Bass PS, Williams JH, Evans B, Jones DB, Theaker JM, Davies DR.
    J Clin Pathol; 1996 Jan; 49(1):43-7. PubMed ID: 8666684
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 28. [Clinicopathological study of interstitial foam cells in idiopathic membranous nephropathy. Consideration of the appearance of interstitial foam cells in renal tissue].
    Kurihara I, Saito T, Hotta O, Taguma Y, Sudo K, Horigome I, Chiba S, Munakata T, Soma J, Ootaka T, Sato H, Abe K.
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):84-90. PubMed ID: 8717310
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
    Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachtman H.
    BMC Nephrol; 2007 Aug 06; 8():11. PubMed ID: 17683621
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in idiopathic membranous nephropathy.
    Sivridis E, Giatromanolaki A, Touloupidis S, Pasadakis P, Vargemezis V.
    Am J Kidney Dis; 2003 Feb 06; 41(2):360-5. PubMed ID: 12552497
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Membranous glomerulopathy with Bowman's capsular and tubular basement membrane deposits.
    Markowitz GS, Kambham N, Maruyama S, Appel GB, Cohen DJ, Kim RC, Andres GA, D'Agati VD.
    Clin Nephrol; 2000 Dec 06; 54(6):478-86. PubMed ID: 11140809
    [Abstract] [Full Text] [Related]

  • 39. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH, Grcevska L.
    Am J Kidney Dis; 1999 Nov 06; 34(5):911-7. PubMed ID: 10561149
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.